First-Line Chemotherapy

Treatment is given in cycles, commonly every three weeks. Each infusion visit includes blood tests to check counts and kidney function, anti-nausea medicine, then the chemotherapy itself. Patients receiving pemetrexed usually take folic acid and receive vitamin B12 injections to reduce side effects, and a steroid may be prescribed around treatment days. A course often includes several cycles, with scans partway through to check response. Some treatment plans add bevacizumab, a drug that targets blood vessel growth, for suitable patients. Your nurse will explain the exact schedule and supportive medicines for your regimen.

Both platinum drugs work with pemetrexed. Cisplatin can be harder on the kidneys and hearing and requires extra IV fluids, so it may not suit people with kidney problems, hearing loss or other conditions. Carboplatin is often easier to tolerate and more commonly lowers blood counts. Your oncologist chooses based on your health, age and treatment goals. Ask why one was chosen for you and what side effects to watch for with that particular drug. Both require careful monitoring through blood tests, and your team may switch between them if side effects become a problem.

Chemotherapy may be given as the main treatment, before or after surgery, or in combination with immunotherapy depending on cell type and current guidelines. Epithelioid disease has often been treated with chemotherapy-based approaches, while immunotherapy combinations have shown particular value for non-epithelioid types. Guidance continues to evolve as new studies report. If you are offered chemotherapy alone, it is reasonable to ask whether immunotherapy or a trial was considered and why the recommended option fits you best. Your oncologist can explain how current guidance applies to you. Plans may also change based on scan results partway through the course.

1. 1

   Ask which platinum drug you will receive and why it was chosen for you.

2. 2

   Start folic acid and attend vitamin B12 injections exactly as your team instructs.

3. 3

   Ask whether immunotherapy or a combination was considered for your cell type.

4. 4

   Keep a calendar of infusion dates, blood tests and planned response scans.